Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Clinical trial NCT05879926 · RECRUITING
Trial details
- NCT number
- NCT05879926
- Sponsor
- NRG Oncology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-18
- Primary completion
- 2032-01-01
- Enrollment
- 3960
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.